Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong
· Delayed Price · Currency is HKD 43.88
+2.18 (5.23%)
Mar 10, 2026, 3:56 PM HKT
HKG:6609 Revenue
Shanghai HeartCare Medical Technology Corporation had revenue of 185.52M CNY in the half year ending June 30, 2025, with 69.29% growth. This brings the company's revenue in the last twelve months to 334.94M, up 33.31% year-over-year. In the year 2024, Shanghai HeartCare Medical Technology Corporation had annual revenue of 277.90M with 19.61% growth.
Revenue (ttm)
334.94M CNY
Revenue Growth
+33.31%
P/S Ratio
4.30
Revenue / Employee
1.02M CNY
Employees
327
Market Cap
1.58B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.71B |
| Cryofocus Medtech (Shanghai) | 93.32M |
| Venus Medtech (Hangzhou) | 468.17M |
| Gaush Meditech | 1.58B |
| MicroTech Medical (Hangzhou) | 482.95M |
| Broncus Holding | 47.72M |
| Acotec Scientific Holdings | 649.64M |
| Vincent Medical Holdings | 869.70M |